Open Access

Effects of mirtazapine on quality of life of Thai patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled trial


Cite

Figure 1

Flow diagram of trial of mirtazapine for patients with fibromyalgia syndrome using a randomized parallel design and placebo control.
Flow diagram of trial of mirtazapine for patients with fibromyalgia syndrome using a randomized parallel design and placebo control.

Figure 2

Mean of the score for the bodily pain domain of SF-36 QoL for patients with FMS receiving placebo (solid circles, solid line), mirtazapine 15 mg/d (solid triangles, dashed line), or 30 mg/d (open circles, dotted line) at visits 1, 4, 5, and 6.aP < 0.05 (mean change from placebo baseline), bP < 0.05 (mean change from mirtazapine 15 mg/d baseline), cP < 0.05 (mean change from mirtazapine 30 mg/d baseline). For clarity, error bars are not shown (see Table 5).
Mean of the score for the bodily pain domain of SF-36 QoL for patients with FMS receiving placebo (solid circles, solid line), mirtazapine 15 mg/d (solid triangles, dashed line), or 30 mg/d (open circles, dotted line) at visits 1, 4, 5, and 6.aP < 0.05 (mean change from placebo baseline), bP < 0.05 (mean change from mirtazapine 15 mg/d baseline), cP < 0.05 (mean change from mirtazapine 30 mg/d baseline). For clarity, error bars are not shown (see Table 5).

Mean scores for each domain of the SF-36 QoL in patients with fibromyalgia syndrome in each group at visits 1, 4, 5, and 6 compared with baseline

Quality of life domains (scales 0–100)Placebo Mean ± SEM (n = 13)Mirtazapine 15 mg Mean ± SEM (n = 13)Mirtazapine 30 mg Mean ± SEM (n = 14)
Bodily pain
Visit 134 ± 15.540 ± 14.628 ± 8.8
Visit 448 ± 11.2

P<0.05

48 ± 19.148 ± 17.4

P<0.05

Visit 546 ± 10.4

P<0.05

54 ± 22.952 ± 22.1

P<0.05

Visit 649 ± 18.458 ± 18.2

P<0.05

57 ± 19.0

P<0.05

General health
Visit 138 ± 20.437 ± 21.236 ± 16.5
Visit 448 ± 15.547 ± 19.448 ± 20.4
Visit 548 ± 18.7854 ± 21.3

P<0.05

50 ± 23.2
Visit 647 ± 17.259 ± 18.2

P<0.05

53 ± 23.4

P<0.05

Mental health
Visit 157 ± 13.871 ± 14.763 ± 16.9
Visit 467 ± 13.280 ± 12.278 ± 11.1

P<0.05

Visit 574 ± 12.1

P<0.05

86 ± 11.7

P<0.05

85 ± 11.3

P<0.0001

Visit 672 ± 11.5

P<0.05

81 ± 14.483 ± 12.4

P<0.05

Physical functioning
Visit 155 ± 4.171 ± 5.960.7 ± 3.8
Visit 461 ± 5.475 ± 6.872.9 ± 4.9

P<0.0001

Visit 558 ± 5.478 ± 5.272.1 ± 6.0

P<0.05

Visit 658 ± 7.280 ± 5.176.7 ± 6.0

P<0.05

Role limitation because of emotional problems
Visit 128 ± 30.059.0 ± 38.933.3 ± 39.2
Visit 467 ± 36.5

P<0.05

77.8 ± 38.575.0 ± 40.5

P<0.05

Visit 573 ± 29.1

P<0.05

86.1 ± 22.369.4 ± 46.0

P<0.05

Visit 664 ± 40.788.9 ± 16.4

P<0.05

75.0 ± 38.0

P<0.05

Role limitation because of physical problems
Visit 123 ± 29.744 ± 43.520 ± 26.3
Visit 446 ± 31.358 ± 44.457 ± 44.1

P<0.05

Visit 557 ± 42.0

P<0.05

67 ± 41.7

P<0.05

65 ± 41.9

P<0.05

Visit 657 ± 46.263 ± 37.765 ± 45.8

P<0.05

Social functioning
Visit 149 ± 14.853 ± 5.551.8 ± 9.6
Visit 456 ± 6.5

P<0.05

50 ± 13.156.3 ± 6.5
Visit 552 ± 9.450 ± 9.247.9 ± 14.9
Visit 653 ± 9.848 ± 9.052.1 ± 4.9
Vitality
Visit 143 ± 15.659 ± 21.949 ± 15.7
Visit 452 ± 10.665 ± 22.661 ± 14.0

P<0.05

Visit 558 ± 10.8

P<0.05

70 ± 23.865 ± 17.8

P<0.05

Visit 659 ± 11.2

P<0.05

64 ± 17.266 ± 17.9

P<0.05

Precoded and recoded values for question Nos. 7 and 8 of the SF-36 QoL questionnaire

Precoded and recoded values for question No. 7
Response choicesPrecoded valueRecoded value
None16
Very mild25.4
Mild34.2
Moderate43.1
Severe52.2
Very severe61

Baseline QoL of Thai patients with FMS compared with Thai HVs

CharacteristicHVs (n = 80)FMS (n = 76)
Mean (SD)Mean (SD)
Bodily pain (0–100)87 (14.7)33 (15. 9)
How much bodily pain have you had during5.5 (0.7)2.5 (0.7)
the past 4 weeks? (1–6)
During the past 4 weeks, how much did pain5.3 (1.0)2.8 (1.0)
interfere with your normal work? (1–6)
General health (0–100)84 (16.0)36 (19.7)
In general, would you say your health is? (1–6)3.7 (0.8)2.0 (1.0)
How true or false is each of the following
statements for you? (1–6)
I seem to get sick a little easier than other people4.6 (0.9)2.7 (1.4)
(definitely true, mostly true, don’t know)
I am as healthy as anybody I know4.6 (0.8)2.5 (1.2)
I expect my health to get worse4.5 (1.0)3.0 (1.3)
My health is excellent4.3 (0.9)1.9 (1.0)
Mental health (0–100)82 (14.5)63 (17.1)
Have you been a very nervous person? (1–6)5.0 (0.8)3.8 (1.1)
Have you felt so down in the dumps that nothing5.8 (0.6)5.1 (1.0)
could cheer you up? (1–6)
Have you felt calm and peaceful? (1–6)4.6 (1.2)3.2 (1.2)
Have you felt down hearted and blue? (1–6)5.4 (0.9)4.7 (1.1)
Have you been a happy person? (1–6)4.7 (1.2)3.8 (1.3)
Physical functioning (0–100)96 (8.2)59 (21.6)
Vigorous activities (1–3)2.7 (0.5)1.5 (0.6)
Moderate activities (1–3)3.0 (0.2)2.0 (0.7)
Lifting or carrying groceries (1–3)2.9 (0.3)1.9 (0.7)
Climbing several flights of stairs (1–3)2.9 (0.4)1.9 (0.7)
Climbing one flight of stairs (1–3)3.0 (0.1)2.7 (0.5)
Bending, kneeling, or stooping (1–3)2.9 (0.4)1.9 (0.7)
Walking more than a mile (1–3)3.0 (0.2)1.9 (0.8)
Walking several blocks (1–3)3.0 (0.1)2.3 (0.7)
Walking one block (1–3)3.0 (0.0)2.7 (0.6)
Bathing or dressing yourself (1–3)3.0 (0.0)2.9 (0.4)
Role limitation because of emotional problems (0–100)92 (24.9)41 (37.9)
Cut down the amount of time you spent on work1.9 (0.3)1.3 (0.5)
or other activities (12)
Accomplished less than you would like (1–2)1.9 (0.3)1.4 (0.5)
Didn’t do work or other activities as carefully as usual (1–2)1.9 (0.3)1.5 (0.5)
Role limitation because of physical problems (0–100)96 (19.4)30 (37.0)
Cut down the amount of time you spent on work1.9 (0.2)1.2 (0.4)
or other activities (1–2)
Accomplished less than you would like (1–2)2.0 (0.2)1.3 (0.5)
Were limited in the kind of work or other activities (1–2)2.0 (0.2)1.4 (0.5)
Had difficulty performing the work or other activity (1–2)2.0 (0.2)1.3 (0.5)
Social functioning (0–100)93 (14.8)53 (12.3)
During the past 4 weeks, to what extent has your4.8 (0.5)3.8 (1.0)
physical health or emotional problem interfered
with your normal social activities with family,
friends, neighbors, or groups? (1–5)
During the past 4 weeks, how much of the time4.6 (0.9)3.5 (1.0)
has your physical health or emotional problem
interfered with your social activities? (1–5)
Vitality (0–100)75 (17.6)48 (19.1)
Did you feel full of pep (glad, joyful, pleasant)? (1–6)4.5 (1.2)3.1 (1.3)
Did you have a lot of energy? (1–6)4.5 (1.3)2.9(1.5)
Did you feel worn out? (1–6)5.3 (0.8)4.0 (1.2)
Did you feel tired? (1–6)4.7 (1.0)3.6(1.1)

Between-group comparisons of mean characteristics and bodily pain of patient with FMS at baseline

Baseline characteristicsPlacebo (n = 13)Mir 15 mg (n = 13)Mir 30 mg (n = 14)Mir 15 + 30 mg (n = 27)
Mean (SD) or n (%)
Age (y)47.4 (37.9)42.7 (45.4)43.9 (35.2)43.3 (56.6)
Female, n (%)13 (100)13 (100)14 (100)27 (100)
Body mass index (kg/m2)22.6 (12.3)22.0 (9.0)22.1 (12.0)22.0 (14.5)
Duration of widespread pain (y)4.0 (11.5)3.3 (8.3)3.1(10.1)3.2 (13.0)
Bodily pain (0–100)34 (55.9)40 (52.6)28 (32.9)35 (15.1)

Baseline characteristics of Thai patients with FMS compared with Thai HVs

CharacteristicHV (n = 80)FMS (n= 76)P
Mean (SD)Mean (SD)
Age (y)43.9 (8.5)45.2 (10.5)NS
Female, n (%)77 (96.3)75 (98.7)NS
Bodily pain (0-100)87 (14.7)33 (15.9)<0.001
Body mass index (kg/m2)23.1(3.1)21.8 (3.2)0.012
Duration of widespread pain (y)0 (0)3.8 (3.5)
eISSN:
1875-855X
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, other, Clinical Medicine